SCHEMBL16767246

SCHEMBL16767246

Nc1nc2ccc(Br)cc2c2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.59
ADRB2 P07550 1/20 0.58
CYP1A1 P04798 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP1B1 Q16678 1/20 0.50
APP P05067 2/20 0.46
ADORA2A P29274 2/20 0.46
DCPS Q96C86 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
ADORA2B P29275 1/20 0.46
ADORA1 P30542 1/20 0.46
RXFP1 Q9HBX9 1/20 0.44
BCHE P06276 5/20 0.44
ACHE P22303 5/20 0.44
GRIN1 Q05586 5/20 0.44
GRIN2A Q12879 5/20 0.44
BACE1 P56817 1/20 0.43
PRNP P04156 1/20 0.43
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17752427 0.81 PRNP (0.45) HTTADRB2CYP1A1CYP1A2CYP1B1
SCHEMBL72673 0.78 KDM4E (0.47) HTTAPPADORA2ADCPSADORA3
SCHEMBL861205 0.78 CYP1A1 (0.50) CYP1A1CYP1A2CYP1B1APPADORA2A
SCHEMBL515743 0.78 HTT (0.50) HTTADRB2CYP1A2RXFP1BCHE
SCHEMBL13696895 0.78 ACHE (0.67) HTTADRB2CYP1A1CYP1A2CYP1B1
SCHEMBL18647352 0.78 PRNP (0.62) ADORA2AADORA3ADORA2BADORA1RXFP1
SCHEMBL72801 0.78 DCPS (0.64) HTTCYP1A1CYP1A2CYP1B1APP
SCHEMBL29583288 0.78 DCPS (0.64) HTTCYP1A1CYP1A2CYP1B1APP
SCHEMBL4358438 0.77 HTT (0.68) HTTADRB2ADORA2ADCPS
SCHEMBL29649743 0.77 HTT (0.68) HTTADRB2ADORA2ADCPS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3023477-B1 COMPOSITION, AND LIGHT-EMITTING ELEMENT USING SAME SUMITOMO CHEMICAL CO (JP) 2019-02-06 EP disclosed
US-9929359-B2 Composition and light emitting device using the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-27 US disclosed
US-20160164008-A1 COMPOSITION AND LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-06-09 US disclosed
US-20160164008-A1 COMPOSITION AND LIGHT EMITTING DEVICE USING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-06-09 US disclosed
EP-3023477-A1 COMPOSITION, AND LIGHT-EMITTING ELEMENT USING SAME Sumitomo Chemical Company Limited (JP) 2016-05-25 EP disclosed
US-20150162551-A1 LIGHT-EMITTING COMPOUND CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2015-06-11 US disclosed
US-20150162551-A1 LIGHT-EMITTING COMPOUND CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2015-06-11 US disclosed
US-20150162551-A1 LIGHT-EMITTING COMPOUND CAMBRIDGE DISPLAY TECHNOLOGY LIMITED (GB) 2015-06-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150162551-A1 LIGHT-EMITTING COMPOUND AP3D1, GRIN1, KISS1R HTT 3169/4885ADRB2 2669/4885CYP1A1 3520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.